Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 267Triple Negative Breast Neoplasms 18Neoplasms 9Lymphedema 9Motor Activity 8Breast Cancer Lymphedema 8Breast Cancer Female 8Pathologic Complete Response 6Neoplasm Metastasis 6Colorectal Neoplasms 6Colonic Neoplasms 6Pain 5Fatigue 5Stomach Neoplasms 4Pain, Postoperative 4Recurrence 3Radiodermatitis 3Hereditary Breast and Ovarian Cancer Syndrome 3Endometrial Neoplasms 3Drug-Related Side Effects and Adverse Reactions 3Breast Diseases 3Advanced Breast Cancer 3Treatment Adherence and Compliance 2Thyroid Neoplasms 2Seroma 2Radiation Injuries 2Ovarian Neoplasms 2Melanoma 2Lymphoma 2Lung Neoplasms 2

Interventions

pyrotinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Metastatic Breast Cancer in the Brain × Breast × Clear all
NCT06475443 2024-06-26

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

Henan Cancer Hospital

Phase 2 Not yet recruiting
32 enrolled
Breast

Metastatic Breast Cancer in the Brain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡